GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing

Nan Chen, Hao Shi, Luxia Zhang, Li Zuo, Jingyuan Xie, Danshu Xie, Amy B. Karger, Shiyuan Miao, Hong Ren, Wen Zhang, Weiming Wang, Yujing Pan, Wei Minji, Zhun Sui, Aghogho Okparavero, Andrew Simon, Juhi Chaudhari, John H. Eckfeldt, Lesley A. Inker, Andrew S. Levey

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Rationale & Objectives: Estimated glomerular filtration rate (eGFR) using creatinine and cystatin C (eGFRcr-cys) may be less accurate compared to measured GFR (mGFR) in China than in North America, Europe, and Australia due to variation across regions in their non-GFR determinants. The non-GFR determinants of β2-microglobulin (B2M) and β-trace protein (BTP) differ from those of creatinine and cystatin C. Thus, the average eGFR using all 4 markers (eGFRavg) could be more accurate than eGFRcr-cys in China. Study Design: Diagnostic test study. Setting & Participants: 1,066 participants in Shanghai and Beijing with creatinine and cystatin C and 666 participants with all 4 filtration markers. Tests Compared: Index tests were previously developed equations for eGFR using creatinine, cystatin C, B2M, and BTP and combinations. The reference test was mGFR using plasma clearance of iohexol. We compared the performance of eGFRavg to eGFRcr-cys using the proportion of participants with errors in eGFR >30% of mGFR (1 − P30) and root mean square error (RMSE) of the regression of eGFR on mGFR on the logarithmic scale. We also compared classification and reclassification of mGFR categories using eGFRavg compared to eGFRcr-cys. Outcomes: Accuracy was significantly better for eGFRavg (1 − P30 of 10.4% and RMSE of 0.214) compared to eGFRcr-cys (1 − P30 of 13.8% and RMSE of 0.232; P = 0.004 and P = 0.006, respectively). However, improvements in accuracy did not generally translate into significant improvement in classification or reclassification of mGFR categories. Limitations: Study population may not be generalizable to clinical settings other than large urban medical centers in China. Conclusions: A panel of endogenous filtration markers including B2M and BTP in addition to creatinine and cystatin C may improve GFR estimation in China. Further study is necessary to determine whether GFR estimation using B2M and BTP can be improved and whether these improvements lead to useful clinical applications.

Original languageEnglish (US)
Pages (from-to)172-180
Number of pages9
JournalKidney Medicine
Issue number2
StatePublished - Mar 1 2020

Bibliographical note

Publisher Copyright:
© 2020 The Authors


  • China
  • Estimated GFR
  • beta-2 microglobulin
  • beta-trace protein
  • creatinine
  • cystatin C


Dive into the research topics of 'GFR Estimation Using a Panel of Filtration Markers in Shanghai and Beijing'. Together they form a unique fingerprint.

Cite this